CEO of Entrada Therapeutics
CEO of Entrada Therapeutics
Education
B.S. in Finance from University of Connecticut, MBA from University of Chicago Booth School of Business
Born
January 1, 1983 - 42 years ago
Economy Sector
Healthcare
Current Tenure
1 year 1 month (Jan 2024 - Present)
Previous Experience
Chief Operating Officer at Entrada Therapeutics, Senior VP at Rubius Therapeutics
CEO of Entrada Therapeutics
CEO of Entrada Therapeutics
No compensation data available for Nathan J. Dowden yet. Come back soon!